Li, L.; Abraham, A.D.; Zhou, Q.; Ali, H.; O'Brien, J.V.; Hamill, B.D.; Arcaroli, J.J.; Messersmith, W.A.; LaBarbera, D.V.
An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent. Mar. Drugs 2014, 12, 4833-4850.
https://doi.org/10.3390/md12094833
AMA Style
Li L, Abraham AD, Zhou Q, Ali H, O'Brien JV, Hamill BD, Arcaroli JJ, Messersmith WA, LaBarbera DV.
An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent. Marine Drugs. 2014; 12(9):4833-4850.
https://doi.org/10.3390/md12094833
Chicago/Turabian Style
Li, Linfeng, Adedoyin D. Abraham, Qiong Zhou, Hadi Ali, Jeremy V. O'Brien, Brayden D. Hamill, John J. Arcaroli, Wells A. Messersmith, and Daniel V. LaBarbera.
2014. "An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent" Marine Drugs 12, no. 9: 4833-4850.
https://doi.org/10.3390/md12094833
APA Style
Li, L., Abraham, A. D., Zhou, Q., Ali, H., O'Brien, J. V., Hamill, B. D., Arcaroli, J. J., Messersmith, W. A., & LaBarbera, D. V.
(2014). An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent. Marine Drugs, 12(9), 4833-4850.
https://doi.org/10.3390/md12094833